Tianyin Pharmaceutical Co., Inc. to Present at the 22nd Annual ROTH Capital Partners OC Growth Stock Conference on March 16
CHENGDU, China, March 12 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Alternext: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced it will present at 22nd Annual ROTH Capital Partners (ROTH) OC G...
Tianyin Pharmaceutical Co., Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing on March 9
BEIJING, March 4 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Alternext: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced it will present at the Rodman & Renshaw Annual China Investment Conference bei...
Tianyin Pharmaceutical Co., Inc. Expects to Benefit from the Recently Published Guide to Pricing Reform for Medicine and Medical Services
Key Government Objectives aimed to align prices with the quality of medications while accelerating growth for Chinese Traditional Medicines CHENGDU, China, Feb. 9 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a manufacturer and supplier of modernized traditional...
Tianyin Pharmaceutical Co., Inc. Announces Record Second Quarter 2010 Financial Results
CHENGDU, China, Feb. 9 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Alternext: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced fiscal results for its second quarter ended December 31, 2009. -- Q...
Tianyin Pharmaceutical Co., Inc. to Host Second Fiscal Quarter 2010 Results Earnings Conference Call on Monday, February 8, 2010 at 4:30 p.m. ET
CHENGDU, China, Feb. 2 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") and Western Pharmaceuticals based in Chengdu, China, today announced that management will host a conference call to discu...
Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA Approval for Ofloxacin and Fleroxacin
Products Expand Company's Antibiotic Portfolio and Target New Indications CHENGDU, China, Jan. 13 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") and Western Pharmaceuticals based in Ch...
Tianyin Pharmaceutical, Co., Inc. Announces Cash Dividend to Common Shareholders - Record Date January 29, 2010
CHENGDU, China, Jan. 11 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Co., Inc. (NYSE Amex: TPI), a developer, manufacturer and supplier of modernized traditional Chinese medicine ("TCM") and generic pharmaceuticals in China, today declared a quarterly cash dividend to be paid to its common stock ...
Tianyin Pharmaceutical Co., Inc. Has 23 Medicines Included in China's National Insurance Directory
CHENGDU, China, Jan. 7 /PRNewswire-Asia/ - Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") and Western Pharmaceuticals based in Chengdu, China, today announced that 23 of its medicine compounds will be included in...
Tianyin Pharmaceutical Co., Inc. Provides Fiscal 2011 Guidance
CHENGDU, China, Dec. 3 /PRNewswire-Asia/ -- -- Management expects to report revenues of approximately $113.3 million and net income of approximately $19.6 million for the Fiscal Year which ends June 30, 2011, representing approximately 78.1% and 73.5% growth over fiscal 2010 guidance ...
Tianyin Pharmaceutical Co., Inc. Receives Chinese SFDA New Product Approvals for 2 Generic Products
Pediatric Fever and Cough Oral Liquid Address Large Market Antibacterial and Anti-inflammatory Capsules to Be Manufactured in Company's New Facility CHENGDU, China, Dec. 1 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a manufacturer and supplier of mo...
Tianyin Pharmaceutical co., Inc. Announces Record First Quarter 2010 Financial Results
-- Q1 2010 Revenue Increased 40.2% to $13.4 Million, Net Income Increased 22.3% to $2.2 Million with EPS of $0.08 vs. $0.07 -- Cash and Equivalents of $14.4 Million on September 30, 2009 -- First Quarter 2010 Cash Flow from Operations Increased 345.5% to $2.2 mil...
Tianyin Pharmaceutical Co., Inc. to Host First Quarter Fiscal 2010 Earnings Conference Call and Webcast on Friday, November 13th, 2009 at 10:30 a.m. ET
CHENGDU, China, Nov. 9 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical, Co., Inc., (NYSE Amex: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ('TCM') based in Chengdu, China, today announced that management will hold a conference call to discuss its fiscal ...
Tianyin Pharmaceutical Co., Inc. Updates Fiscal 2010 Guidance and Announces Joint Venture with Sichuan Mingxin Pharmaceutical Co. to Pursue Macrolide Antibiotics Growth Initiative
-- Company Updates Fiscal 2010 Guidance: Management expects Revenue and Net Income of $63.6 million and $11.3 million -- Company Anticipates Organic Growth and JV to Generate Significant Future Growth in Fiscal 2011 and 2012 CHENGDU, China, Oct. 30 /PRNewswire-Asia/ -- Tianyin Pharmaceut...
Tianyin Pharmaceutical, Co. Announces Cash Dividend to Common Shareholders - Record Date October 30, 2009
CHENGDU, China, Oct. 5 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co. Inc. (NYSE Amex: TPI), a developer, manufacturer and supplier of modernized traditional Chinese medicine ("TCM") and generic pharmaceuticals in China, today declared a quarterly cash dividend to be paid to its c...
Tianyin Pharmaceutical, Co. to Present at the Roth China Conference on October 14 at 12:30 pm ET
CHENGDU, China, Sept. 30 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co. Inc. (NYSE Amex: TPI), a developer, manufacturer and supplier of modernized traditional Chinese medicine ("TCM") and generic pharmaceuticals in China, today announced that it will present at the Roth China Con...
Tianyin Pharmaceutical Co., Inc. Appoints Mr. Tao Yang as Chief Operating Officer
CHENGDU, China, Sept. 28 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced the appointment of Mr. Tao Yang to the position of Chief Operati...
Tianyin Pharmaceutical Co., Inc. Reports Record Fiscal 2009 Financials With $7.9 Million in Net Income
CHENGDU, China, Sept. 24 /PRNewswire-Asia-FirstCall/ -- -- Q4 FY 2009 Revenues increased 43.2% to $13.3 Million, Net Income increased 41.8% to $2.2 Million with diluted EPS of $0.08 -- FY 2009 Revenues increased 28.2% to $42.9 Million and Net Income Increased 32.4% ...
Tianyin Pharmaceutical Co., Inc. to Host Fiscal 2009 Earnings Conference Call on Thursday, September 24, 2009 at 10:30 a.m. ET
CHENGDU, China, Sept. 17 /PRNewswire-Asia/ -- Tianyin Pharmaceutical, Co., Inc., (NYSE: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ('TCM') based in Chengdu, China, today announced that management will hold a conference call to discuss its fiscal 2009 fourth quar...
Tianyin Pharmaceutical Co., Inc. Obtains GMP Certification for Its New Production Facility
CHENGDU, China, Sept. 16 /PRNewswire-Asia/ -- Tianyin Pharmaceutical Co., Inc., (NYSE AMEX: TPI), a manufacturer and supplier of modernized traditional Chinese medicines ("TCM") today announced that its new production facility obtained the Good Manufacturing Practices Certificate for pharmaceuti...
Tianyin Pharmaceutical Co., Inc. Has Four Products Included in China's Essential Drug List
CHENGDU, China, Sept. 10 /PRNewswire-Asia/ - Tianyin Pharmaceutical Co., Inc., (NYSE Amex: TPI), a manufacturer and supplier of modernized traditional Chinese medicine ("TCM") based in Chengdu, China, today announced that it has four products included in China's Essential Drug List (EDL) release...
